Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzaeIan Morrissey, Glenn TillotsonP & T : a Peer-Reviewed Journal for Formulary Management|September 6, 2019
Antibiotic Breakpoints: How Redefining Susceptibility Preserves Efficacy and Improves Patient CareMark Redell, Glenn TillotsonExpert Review of Respiratory Medicine|November 14, 2023
A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challengesKamal A Hamed, Glenn TillotsonInternational Journal of Antimicrobial Agents|February 16, 2008
Role of gemifloxacin in the management of community-acquired lower respiratory tract infectionsJoseph M Blondeau, Glenn TillotsonBMC Infectious Diseases|March 7, 2023
The burden of CDI in the United States: a multifactorial challengePaul Feuerstadt, Nicolette Theriault, Glenn TillotsonExpert Review of Anti-Infective Therapy|October 7, 2009
Topical antibiotic treatment for uncomplicated skin and skin structure infections: review of the literatureRonald Pangilinan, Alan Tice, Glenn TillotsonClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2019
Analysis of Pooled Phase 3 Safety Data for Delafloxacin in Acute Bacterial Skin and Skin Structure InfectionsMatteo Bassetti, David Hooper, Glenn TillotsonInfection and Drug Resistance|February 20, 2024
Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the DetailsLea Monday, Glenn Tillotson, Teena ChopraAdvances in Therapy|September 14, 2024
The 3 Ds: Depression, Dysbiosis, and Clostridiodes difficileAntoine Boustany, Paul Feuerstadt, Glenn TillotsonFrontiers in Medicine|January 26, 2023
Gut microbiota and microbiota-based therapies for Clostridioides difficile infectionTeena Chopra, Gail Hecht, Glenn TillotsonPageof 5